As shown in Fig. 3, WDFY3-AS2 expression was downregulated along with histological grades, and the decreased expression was also observed in classical, mesenchymal, MGMT promoter unmethylated, LGG IDH-wt or GBM IDH-wt stratified patients. The gene discussed is MGMT; the disease is glioblastoma.